Skip to main content
. 2008 Jan;2(1):20–23. doi: 10.4103/0973-6247.39507

Table 5.

Repeat pre-transfusion testing, blood center

Initial sample Post-cefotetan
ABO A A
Rh phenotype DEce DEce, mixed field
DAT
 IgG 2+ 4+
 C3 w+ vw+
 Antibody screen Negative 3+*
*

Positive at AHG phase with all cells